A study has demonstrated that a short course of cognitive functional therapy (CFT) can provide long-lasting relief for individuals suffering from c...
A short-term course of cognitive functional therapy (CFT) has been found to significantly relieve chronic lower back pain for up to three years. Th...
A new treatment known as cognitive functional therapy (CFT) has been found to provide long-lasting relief for individuals suffering from chronic lo...
IGC Pharma has announced promising preclinical data on its investigational molecule IGC-M3, which targets multiple biological mechanisms central to...
A study investigated the mechanism of Yiqi Ziyin (YQZY), a traditional Chinese medicine formula, in treating immune thrombocytopenia (ITP). ITP is ...
A five-year-old boy named Harrison is facing significant health challenges due to a rare genetic condition affecting only 15 people globally. Harri...
Vertex Pharmaceuticals has announced the results of its Phase 2 study evaluating VX-993, a selective NaV1.8 pain signal inhibitor, for treating acu...
Marea Therapeutics has enrolled the first patient in its Phase 2b TYDAL-TIMI 78 clinical study, which evaluates the drug MAR001 in adults at risk o...
Ethris GmbH has commenced a Phase 2a clinical trial for its mRNA-based candidate ETH47, aimed at reducing asthma symptoms triggered by rhinovirus. ...
A five-year-old boy named Harrison is facing a rare genetic condition that affects only 15 people worldwide. The condition, a mutation in the Filam...